Self-management support interventions to reduce health care utilisation without compromising outcomes: a systematic review and meta-analysis by Panagioti, M. et al.
Panagioti, M., Richardson, G., Small, N., Murray, E., Rogers, A., Kennedy, A., Newman, S. P. & 
Bower, P. (2014). Self-management support interventions to reduce health care utilisation without 
compromising outcomes: a systematic review and meta-analysis. BMC Health Services Research, 
14, p. 356. doi: 10.1186/1472-6963-14-356 
City Research Online
Original citation: Panagioti, M., Richardson, G., Small, N., Murray, E., Rogers, A., Kennedy, A., 
Newman, S. P. & Bower, P. (2014). Self-management support interventions to reduce health care 
utilisation without compromising outcomes: a systematic review and meta-analysis. BMC Health 
Services Research, 14, p. 356. doi: 10.1186/1472-6963-14-356 
Permanent City Research Online URL: http://openaccess.city.ac.uk/8091/
 
Copyright & reuse
City University London has developed City Research Online so that its users may access the 
research outputs of City University London's staff. Copyright © and Moral Rights for this paper are 
retained by the individual author(s) and/ or other copyright holders.  All material in City Research 
Online is checked for eligibility for copyright before being made available in the live archive. URLs 
from City Research Online may be freely distributed and linked to from other web pages. 
Versions of research
The version in City Research Online may differ from the final published version. Users are advised 
to check the Permanent City Research Online URL above for the status of the paper.
Enquiries
If you have any enquiries about any aspect of City Research Online, or if you wish to make contact 
with the author(s) of this paper, please email the team at publications@city.ac.uk.
RESEARCH ARTICLE Open Access
Self-management support interventions to reduce
health care utilisation without compromising
outcomes: a systematic review and meta-analysis
Maria Panagioti1*, Gerry Richardson2, Nicola Small1, Elizabeth Murray3, Anne Rogers4, Anne Kennedy4,
Stanton Newman5 and Peter Bower1
Abstract
Background: There is increasing interest in the role of ‘self-management’ interventions to support the
management of long-term conditions in health service settings. Self-management may include patient education,
support for decision-making, self-monitoring and psychological and social support. Self-management support has
potential to improve the efficiency of health services by reducing other forms of utilisation (such as primary care
or hospital use), but a shift to self-management may lead to negative outcomes, such as patients who feel more
anxious about their health, are less able to cope, or who receive worse quality of care, all of which may impact on
their health and quality of life. We sought to determine which models of self-management support are associated
with significant reductions in health services utilisation without compromising outcomes among patients with
long-term conditions.
Methods: We used systematic review with meta-analysis. We included randomised controlled trials in patients
with long-term conditions which included self-management support interventions and reported measures of service
utilisation or costs, as well as measures of health outcomes (standardized disease specific quality of life, generic quality
of life, or depression/anxiety).We searched multiple databases (CENTRAL, CINAHL, Econlit, EMBASE, HEED, MEDLINE,
NHS EED and PsycINFO) and the reference lists of published reviews. We calculated effects sizes for both outcomes
and costs, and presented the results in permutation plots, as well as conventional meta-analyses.
Results: We included 184 studies. Self-management support was associated with small but significant improvements
in health outcomes, with the best evidence of effectiveness in patients with diabetic, respiratory, cardiovascular and
mental health conditions. Only a minority of self-management support interventions reported reductions in
health care utilisation in association with decrements in health. Evidence for reductions in utilisation associated
with self-management support was strongest in respiratory and cardiovascular problems. Studies at higher risk
of bias were more likely to report benefits.
Conclusions: Self-management support interventions can reduce health service utilization without compromising
patient health outcomes, although effects were generally small, and the evidence was strongest in respiratory and
cardiovascular disorders. Further work is needed to determine which components of self-management support are
most effective.
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Background
With the increasing prevalence of long-term conditions
[1], and with many patients reporting multimorbidity
[2], there is worldwide interest in innovations in service
delivery that can better manage these patients [3]. The
global financial crisis and subsequent constraint on
spending has led to a shift in focus to more efficient
models of care which can reduce high cost service use
such as emergency hospital admissions. This has in turn
led to a focus on patients at high risk of high utilisation,
with the introduction of algorithms to identify those
patients and complex case management interventions to
manage them. However, evidence of the effectiveness of
this approach is limited [4], and recent commentators
have highlighted that a focus on very high risk cases
limits impact, because they account for only a small
proportion of overall health care use [5].
This has increased interest in the wider group of pa-
tients with long-term conditions. It has been suggested
that many patients with long-term conditions can be
managed effectively by effective support for ‘self-man-
agement’. Self-management has been defined as ‘the
care taken by individuals towards their own health and
well being: it comprises the actions they take to lead a
healthy lifestyle; to meet their social, emotional and
psychological needs; to care for their long-term condi-
tion; and to prevent further illness or accidents’, and
can include responding to symptoms, managing acute
episodes, relaxation, exercise and smoking cessation,
managing the emotional impact of conditions, and
working effectively with health professionals and other
community resources [6]. Self-management support in
the United Kingdom National Health Service is provided
through various platforms, including increasing access to
health information [7], deployment of assistive technolo-
gies such as telehealth and telecare [8,9]; community
based skills-training and support networks [10-12], and
interventions led by health professionals [13].
Self-management and demand management
A key driver of the interest in self-management is the
potential to make a significant contribution to efficient
health care delivery [14], by increasing patient engage-
ment in care, improving uptake of preventive activities,
and reducing reliance on formal health care services by
better management of existing conditions. However, the
scale of the contribution of self-management to the
management of demand is unclear. Positive reports of
impacts of self-management support on health care
utilisation [15] have not always been replicated [16],
and some self-management interventions may increase
demand [17].
In economic terms, efficiency involves maximising out-
comes for a given cost or minimising costs for a given
level of outcome. When interventions improve outcomes
and increase costs (see Figure 1), decision-makers are
faced with decisions about ‘allocative efficiency’, where
additional resources are needed for a new service, which
may incur opportunity costs for other groups of patients
[18]. However, in the context of financial pressures, there
may be equal interest in the interventions which are less
costly and at least as effective as current treatments
(known as ‘technically efficient’ interventions) [18]. There
is an implicit assumption that self-management support
has the potential to be technically efficient. This may
occur by patients undertaking care traditionally done by
health professionals (for example, monitoring of blood
pressure), or by better management of long-term con-
ditions, which enables complications and crises (and
subsequent hospital admission) to be avoided.
However, increasing self-management is not uncom-
plicated. If patients are poorly prepared for new roles,
they may suffer negative outcomes. Increasing the role
of patients in the management of long-term conditions,
while reducing access to formal services, may result in
anxiety, coping difficulties, and reduced quality of care.
Achieving cost savings while significantly reducing patient
quality of life would be a poor outcome for health services
and patients.
The research question underlying this review was: What
models of self-management support are associated with
significant reductions in health services utilisation without
compromising outcomes, among patients with long-term
conditions?
Methods
The review protocol is available as part of the PROSPERO
database (registration number: CRD42012002694). Minor
deviations from the published protocol were made in data
extraction procedures because of the large number of
studies identified by the review.
Population
We included studies of patients with a long-term con-
dition, defined generically as ‘one that cannot be cured
but can be managed through medication and/or ther-
apy.’ This included common physical conditions such
as diabetes, asthma, coronary heart disease, and mental
health conditions such as depression. We also included
studies recruiting patients with a mix of long-term condi-
tions, and those recruiting on the basis of multimorbidity.
We excluded subjects under 18 years of age, and studies
conducted in the developing world.
Intervention
For the purposes of the review, we defined a self-
management support intervention as:
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‘An intervention primarily designed to develop the
abilities of patients to undertake management of health
conditions through education, training and support to
develop patient knowledge, skills or psychological and
social resources’.
We included all formats and delivery methods (group
or individual, face to face or remote, professional or peer
led). We included all studies which included a significant
component of self-management support. After initial
screening of a proportion of the studies, we distinguished
2 categories:
 ‘Self-management’ including provision of materials and
support from a health professional or trained peer. We
coded the amount of support as in three categories for
descriptive purposes: ‘pure’ self-management (no
support), ‘supported self-management’ (up to 2 hours
of additional support for the total durationof the study)
and ‘intensively supported self-management’ (more
than 2 hours of additional support).
 ‘Case management’ (with more than 2 hours of
additional support, and including input from a
multidisciplinary team).
Two authors independently assessed the type of inter-
vention and disagreements were resolved via discussion.
Comparisons
We included studies where the self-management support
intervention was compared against usual care alone, or
Figure 1 PRISMA flow diagram.
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where the self-management support intervention was
compared against a more intensive ‘usual care’ interven-
tion (e.g. self-management versus conventional hospital
use). We excluded studies where two versions of self-
management support interventions were compared as
such comparisons did not allow assessment of the impact
of the self-management support per se.
Outcomes
We extracted data on core types of health care utilisation,
with a focus on comprehensive measures (i.e. cost sum-
maries including multiple sources of utilisation) or major
cost drivers (i.e. hospital use). Other, more minor costs
(such as medication and primary care visits) were identi-
fied but not analysed. We also separately extracted data
on outcomes relating to patient quality of life and health
outcomes, including standardised measures of disease
specific quality of life outcomes, generic quality of life,
and depression/anxiety. We excluded measures of psy-
chological or clinical variables which did not provide a
direct assessment of health or quality of life, such as
self-management behaviour, self-efficacy, HbA1C or forced
expiratory volume (FEV), as these are likely to be unreliable
indicators of health related quality of life [19].
Study design
We restricted the review to randomised controlled trials.
Identification of studies
We conducted a primary search of multiple databases in
June 2012. Databases included the CENTRAL register of
controlled trials, CINAHL, Econlit, EMBASE, HEED,
MEDLINE, MEDLINE in process, NHS EED and Psy-
cINFO. An example search is listed in Additional file 1.
We also identified eligible studies by checking published
reviews (listed in Additional file 1).
Titles and abstracts were screened for eligibility.
More than 40% of titles and abstracts (n = 5,000) were
screened by 2 researchers independently (kappa =
0.87). Screening of the remaining titles and abstracts
was completed by one reviewer. Approximately one
third of the full texts were screened by 2 reviewers
independently (kappa = 0.85), with the remaining full-
texts screened by one reviewer. The studies had to
fulfil five inclusion criteria to be eligible for inclusion
in the review:
 Randomised controlled trial
 Diagnosis of a long-term condition
 Self-management or case management intervention
 Adults (aged ≥ 18 years)
 Report quantitative data on health care utilization
(hospitalization rates/costs and total costs) and
health outcomes (quality of life, depression and
anxiety). Studies reporting non-amenable data
for meta-analysis on both, health outcomes and
health care utilization, were excluded from the
review.
Data extraction
Descriptive data on studies, populations and interventions
were extracted by 2 researchers working independently.
A subset of data on quantitative outcomes (n = 50) were
extracted by 2 members of the research team working
independently, with the rest of the data extracted by
one member and checked by a second.
We extracted data on the effect of self-management
interventions on health care utilisation and total costs.
To assess study quality, we chose a dichotomous measure
based on allocation concealment, as this is consistently
associated with treatment effect [20,21]. Allocation con-
cealment was judged as adequate or inadequate according
to the Cochrane risk of bias tool. We analysed outcomes,
grouping by risk of bias to assess whether results varied
by study quality.
Analyses
We calculated standardised mean differences for health
outcomes and costs using reported data or appropriate
transformation and imputation [22]. Some measures of
utilisation (e.g. hospital length of stay) and costs demon-
strate significant skew. In line with published reviews,
we identified those outcomes where the standard devi-
ation multiplied by two was greater than the mean, as
this indicates that the mean is not a good indicator of
the centre of the distribution [23,24], although skewed
data are less problematic if the sample size is large. Cluster
trials were identified and the precision of analyses adjusted
using a sample size/variation inflation method [25], as-
suming an intra-class correlation of 0.02. Studies reporting
multiple self-management interventions were treated as
separate comparisons, with appropriate adjustment of
sample sizes to avoid double counting. We explored
statistical heterogeneity through the I2 statistic [26], label-
ling levels of heterogeneity as ‘low’ (0%-25%), ‘moderate’
(26-74%) and ‘high’ (75%+).
We present the results of the included studies according
to a permutation plot [27]. This involves plotting the effect
of interventions on utilisation and outcomes simultan-
eously and placing them in quadrants of the cost effect-
iveness plane depending on the pattern of outcomes.
Such plots identify studies in the appropriate quadrant
(i.e. those that reduce costs without compromising out-
comes) and those in problematic quadrants (i.e. those
that reduce costs but also compromise outcomes, or
those that compromise both outcomes and costs).
Hospital use generally represents a significant driver of
total costs, but limiting analysis to a single cost source
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leaves the analysis vulnerable to cost shifting, where
benefits found in terms of reductions in hospital use
mask increases in costs elsewhere (e.g. to primary care, or
patient out of pocket costs). We presented two permuta-
tion plots, one based on studies reporting a measure
related to hospital use, and one based on total costs.
For each condition, we conducted separate meta-
analyses of the effects of self-management interventions
in trials reporting utilisation outcomes (separately for
total costs and hospital use outcomes) and in trials
reporting health outcomes. We conducted secondary
analyses, exploring differences by study quality (high
and low risk of bias) and country of origin (UK versus
non-UK).
As a secondary analysis, we then identified the subset
of trials of self-management interventions reporting both
utilisation and health outcomes, and conducted a meta-
analysis of the effects of self-management interventions
on utilisation and health outcomes, in this subset of trials.
We conducted these sensitivity analyses in those long-
term conditions where there were at least 10 studies
with both outcomes. We repeated each of these ana-
lyses, distinguishing self-management and case manage-
ment, as defined previously.
We created funnel plots [28] using standard errors [29]
(with associated regression tests) to assess the potential
for small sample bias for each outcome.
Results
Study characteristics
The PRISMA diagram is shown in Figure 1, with study
references listed in Additional file 1. A completed PRISMA
checklist is listed in Additional file 2. Descriptive character-
istics of the studies are provided in Table 1.
Relationships between cost and health outcomes
Figures 2 and 3 show the overall permutation plots,
plotting health outcomes and hospital use outcomes
(Figure 2) and health outcomes and costs (Figure 3). In
terms of hospital use, the bulk of studies are in the
lower right quadrant (i.e. they are associated with
improvements in health outcomes and reductions in
utilisation). Only a minority of studies report decre-
ments in health outcomes, and a smaller proportion of
studies report improved outcomes with increases in
utilisation. In terms of costs, the picture is more mixed,
with more studies in the top right quadrant, reporting
improved outcomes with increases in costs. Note that
the plots do not represent the uncertainty around point
estimates, which in many studies would be considerable.
Of the 71 studies reporting costs, almost all demonstrated
significant skew (i.e. the standard deviation multiplied by
2 was more than twice the mean).
Effects of self-management support on health outcomes
and utilisation
Table 2 shows the impact of self-management support
on hospital use and health outcomes, structured by type
of long-term condition and type of self-management
support. Results are highlighted in the table that show
an effect size of 0.2 (at least a ‘small’ effect by current
convention), where the effect is also statistically signifi-
cant. As can be seen from Table 2, such impacts are
found in a number of cells in relation to health out-
comes, but are restricted to interventions in respiratory
and cardiovascular populations in relation to hospital
use.
Table 1 Basic descriptive data on the studies
Category Characteristics N (n = 184)
Context Country
UK 43 (23%)
US 65 (35%)
European 44 (24%)
Other 32 (17%)
Patients Condition
Arthritis 14 (8%)
Cardiovascular 53 (29%)
Diabetes 11 (6%)
Mental health 29 (16%)
Mixed disease 13 (7%)
Respiratory 44 (24%)
Pain 20 (11%)
Mean Age (SD) 58 (13)
% Male 49%
Intervention Content
Pure SM 9 (5%)
Supported SM 36 (20%)
Intensive SM 87 (47%)
Case management 52 (28%)
Sample size (SD) 275 (272)
Range 23-1801
External validity Excluded patients with other
long-term conditions
65 (35%)
Proportion of eligible patients
who did not take part in the study
Not clear 48 (26%)
<20% 40 (22%)
21-40% 55 (30%)
41-60% 25 (14%)
61-80% 14 (8%)
81-100% 2 (1%)
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Table 3 is structured in the same way, but details the
impact of self-management support on costs and health
outcomes. The patterns are broadly similar, although
effects are now reported for arthritis and pain, but re-
stricted to case management interventions. It should be
noted that some of the differences between Tables 2 and
3 reflect changes in the number of studies included in
the analysis and associated precision of the estimates.
The sensitivity analyses (not shown) showed similar
patterns of results when analyses are restricted to the
subset of studies which report both health outcomes and
utilisation/cost data.
Study quality and small study bias
Table 4 shows the effects of self-management support
on the three core outcomes, grouped according to risk
of bias. Studies judged at high risk of bias reported greater
benefits in health outcomes and greater reductions in
hospitalization than those judged at low risk of bias, al-
though they were also associated with increases in total
costs. Table 5 shows the effects of self-management
support on the three core outcomes, grouped according
to country of origin (UK or other). The results suggest
that studies in the UK demonstrated smaller effects
on health outcomes. Conversely, studies in the UK
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Figure 2 Permutation plot – health outcomes and hospital use outcomes.
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Figure 3 Permutation plot – health outcomes and total costs.
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Table 2 Summary – hospital use (overall ES, 95% CI, N, I2)
Combined QoL Self-management QoL Case management QoL Combined hospital use Self-management
hospital use
Case management
hospital use
Respiratory 0.27 (0.16 to 0.37, n = 34,
moderate)
0.28 (0.16 to 0.41, n = 27,
moderate)
0.19 (0.02 to 0.36, n = 7,
low)
−0.21 (−0.32 to −0.09,
n = 31, moderate)
−0.19 (−0.33 to −0.05, n = 25,
moderate)
−0.26 (−0.42 to −0.10, n = 6,
zero)
Cardiac 0.21 (0.14 to 0.28, n = 40,
moderate)
0.19 (0.10 to 0.27, n = 27,
moderate)
0.26 (0.12 to 0.39, n = 13,
moderate)
−0.23 (−0.34 to −0.13,
n = 38, high)
−0.20 (−0.33 to −0.07, n = 25,
high)
−0.29 (−0.47 to −0.11, n = 13,
high)
Arthritis 0.16 (0.07 to 0.26, n = 11,
zero)
0.17 (0.07 to 0.27, n = 7,
zero)
0.13 (−0.13 to 0.39, n = 4,
zero)
−0.06 (−0.22 to 0.10, n = 6,
moderate)
−0.02 (−0.19 to 0.16, n = 5,
moderate)
−0.24 (−0.48 to 0.00, n = 1,
NA)
Pain 0.13 (0.04 to 0.21, n = 19,
low)
0.12 (0.02 to 0.22, n = 15,
low)
0.20 (−0.10 to 0.50, n = 4,
zero)
−0.03 (−0.34 to 0.28, n = 3,
low)
−0.03 (−0.34 to 0.28, n = 3,
low)
Diabetes 0.44 (0.14 to 0.75, n = 10,
high)
0.44 (0.14 to 0.75, n = 10,
high)
−0.12 −0.29 to 0.05, n = 5,
moderate)
−0.12 −0.29 to 0.05 n = 5,
moderate)
Mental health 0.22 (0.11 to 0.33, n = 26,
high)
0.05 (−0.07 to 0.17, n = 15,
moderate)
0.38 (0.24 to 0.51, n = 11,
high)
−0.03 (−0.10 to 0.04, n = 21,
low)
−0.03 (−0.16 to 0.10, n = 13,
moderate)
−0.04 (−0.13 to 0.05, n = 8,
zero)
Mixed 0.13 (0.02 to 0.24, n = 10,
moderate)
0.11 (−0.03 to 0.24, n = 7,
moderate)
0.22 (−0.03 to 0.48, n = 3,
moderate)
−0.12 (−0.20 to −0.03, n = 11,
moderate)
−0.09 (−0.17 to −0.02, n = 8,
zero)
−0.13 (−0.40 to 0.14, n = 3,
moderate)
Bold letters: > =0.2 and statistically significant effects.
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Table 3 Summary – costs (overall ES, 95% CI, N, I2)
Combined QoL Self-management QoL Case management QoL Combined costs Self-management costs Case management costs
Respiratory 0.27 (0.16 to 0.37, n = 34,
moderate)
0.28 (0.16 to 0.41, n = 27,
moderate)
0.19 (0.02 to 0.36, n = 7,
low)
0.09 (−0.14 to 0.33, n = 9,
high)
0.09 (−0.19, 0.37) N = 6,
high)
0.09 (−0.46 to 0.64, n = 3,
high)
Cardiac 0.21 (0.14 to 0.28, n = 40,
moderate)
0.19 (0.11 to 0.27, n = 27,
moderate)
0.26 (0.12 to 0.39, n = 13,
moderate)
−0.25 (−0.47 to −0.04,
n = 9, moderate)
−0.25 (−0.82, 0.32, n = 4,
high)
−0.27 (−0.44, −0.10, n = 5,
moderate)
Arthritis 0.16 (0.07 to 0.26, n = 11,
zero)
0.17 (0.07 to 0.27, n = 7, zero) 0.13 (−0.13 to 0.39, n = 4,
zero)
0.07 (−0.07 to 0.20, n = 11,
moderate)
0.14 (0.01 to 0.27, n = 8,
moderate)
−0.28 (−0.53 to −0.03, n = 3,
zero)
Pain 0.13 (0.04 to 0.21, n = 19,
zero)
0.12 (0.02 to 0.22, n = 15, low) 0.20 (−0.11 to 0.51, n = 4,
zero)
0.07 (−0.13 to 0.28, n = 13,
high)
0.15 (−0.06 to 0.36, n = 11,
high)
−0.41 (−0.74 to −0.08), n = 2,
zero)
Diabetes 0.44 (0.14 to 0.75, n = 10,
high)
0.44 (0.14 to 0.75, n = 10,
high)
0.19 (−0.18, 0.55, n = 4,
moderate)
0.19 (−0.18, 0.55, n = 4,
moderate)
Mental health 0.22 (0.11 to 0.33, n = 26,
high)
0.05 (−0.07 to 0.17, n = 15,
moderate)
0.38 (0.24 to 0.51, n = 11,
high)
0.03 (−0.05 to 0.11, n = 14,
low)
−0.04 (−0.23 to 0.15, n = 4,
moderate)
0.05 (−0.04 to 0.13, n = 10,
low)
Mixed 0.13 (0.02 to 0.24, n = 10,
moderate)
0.11 (−0.03 to 0.24, n = 7,
moderate)
0.22 (−0.03 to 0.48, n = 3,
low)
0.06 (−0.02 to 0.13, n = 7,
zero)
0.05 (−0.04 to 0.13, n = 6,
zero)
0.11 (−0.09 to 0.31, n = 1,
N/A)
Bold letters: > =0.2 and statistically significant effects.
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demonstrated larger reductions in hospitalisation, but
those were not matched by cost data, where UK studies
showed a moderate increase in overall costs.
The funnel plots for health outcomes (intercept 0.47,
95% CI −0.16 to 1.10, p = 0.14) (Figure 4) and costs
(intercept −0.46, 95% CI −1.71 to 0.79, p = 0.47) (Figure 5)
did not show evidence of small study bias. The plot
for hospital use (intercept −0.91, 95% CI −1.55 to −0.27,
p = 0.01) did show evidence of small study bias (Figure 6).
Discussion
In summary, self-management support interventions gen-
erally had a small but positive impact on health outcomes,
with only a small minority of studies included in the review
reporting decrements in outcomes in the permutation
plots. In terms of the primary utilisation outcome of
hospital use, the evidence was most robust in both scope
and effect in relation to interventions in respiratory and
cardiovascular problems. The magnitude of those effects
was similar in cost outcomes.
Strengths and limitations
The study was conducted and reported in line with
current guidance. The high number of included studies
and the rapid timeframe of the review meant that we
could not use 2 independent researchers for all assess-
ments and extraction, but we tested the reliability and
found high levels of agreement.
Designing searches and inclusion criteria for self-
management is complex, because of the lack of consen-
sus on the scope of the term. Our search was broad, but
was dependent on the existence of key terms in the titles
and abstracts. Additionally, it is not clear how the
search terms for utilisation or other economic outcomes
perform in terms of sensitivity or specificity, although
they were tested against a known set of studies. We did
not find evidence of publication bias in relation to
health outcomes or costs, but there was evidence in
terms of hospital use data.
The broad scope of the review combined with the
large number of studies meant that a less comprehensive
quality assessment was used. This does mean that quality
assessment was very dependent on the exact descriptions
of concealment provided in the papers, and the more
limited quality assessment may not be as reliable as a full
risk of bias assessment.
We required that data were reported in a way that was
amenable to meta-analysis for cost and health outcomes.
Such selection would potentially cause selection effects
in the included studies. We were unable to formally test
differences between eligible studies reporting or not
reporting appropriate data, as data on the latter were
not extracted because of resource limitations, and would
by definition not have allowed assessment of variation in
outcomes.
Our aim (to identify studies that reduce costs while not
compromising outcomes) reflects the current economic
context faced by many commissioners of health care
services, but does not map neatly onto current eco-
nomic analyses, which focus on the incremental cost
effectiveness ratio and net mean benefit. Self-management
interventions which reduce costs without compromising
outcomes might be attractive to commissioners, but so
might interventions which increase costs, while providing
significant additional health benefits.
The most comprehensive assessment of costs would
include all those related to the intervention (NHS services,
social care and other costs, patient direct costs and costs
of lost productivity). However, such comprehensive cost-
ing is rare, and more limited assessments of utilisation still
have utility, as some forms of utilisation (such as hospital
costs) are generally a major driver of total costs. However,
caution must be exercised in interpretation of studies
reporting partial cost data, as there is always the danger of
cost shifting rather than genuine reduction (as evidenced
Table 4 Overall effects by risk of bias
Overall effect size Effect size (high risk of bias) Effect size (low risk of bias)
95% CI 95% CI 95% CI
I2 I2 I2
Health outcomes 0.22 (0.17 to 0.26) 0.23 (0.18 to 0.29) 0.18 (0.12 to 0.25)
Hospital use −0.16 (−0.20 to −0.11) −0.18 (−0.24 to −0.11) −0.10 (−0.16 to −0.04)
Costs 0.02 (−0.05 to 0.08) 0.07 (−0.05 to 0.18) −0.01 (−0.09 to -0.07)
Table 5 Overall effects by country
Overall effect size Effect size (UK studies) Effect size (Non UK studies)
Health outcomes 0.22 (0.17 to 0.26) 0.10 (0.05 to 0.14) 0.25 (0.19 to 0.30)
Hospital use −0.16 (−0.20 to −0.11) −0.23 (−0.35 to −0.11) −0.14 (−0.19 to −0.09)
Costs 0.02 (−0.05 to 0.08) 0.13 (0.02 to 0.24) −0.04 (−0.12 to 0.04)
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in the comparison of Figures 2 and 3). Comprehensive
costing will include the costs of the self-management
intervention itself which is required to generate reductions
in hospital use.
Multimorbidity is prevalent among patients with long-
term conditions, but a recent review of interventions
found few studies [30], and our main analysis has been
in terms of disease categories. It is possible that the re-
sults reported here could be significantly moderated by
multimorbidity [31]. Our analysis assumed that self-
management support is a ‘health technology’ which is
potentially discrete, defined, and capable of being de-
livered in a standardised form. Clearly, many aspects of
self-management are not of this type (such as that pro-
vided within social networks and informal care) [32],
and these forms would have been excluded.
Our analyses showed significant effects of self-manage-
ment interventions for respiratory and cardiovascular
diseases but failed to indicate clear effects for other
long-term conditions. However, over half of the studies
included in the review have been conducted among pa-
tients with these conditions. Failure to obtain clear results
about the effects of self-management interventions on
other conditions may partly reflect lack of power.
We only explored basic moderators of effects (such as
‘self-management’ versus ‘case management’). There are
a large number of factors on which studies differ, and it
is possible in theory to use meta-regression techniques to
explore the ‘active ingredients’ of interventions [33,34].
However, this is dependent on interventions with clearer
boundaries and consensus over definitions. The range of
self-management interventions included in the current re-
view was very wide. When combined with inconsistent
reporting, the utility of meta-regression is more limited.
Similarly, the differences in Tables 4 and 5 should be
interpreted with caution, as the associations with risk of
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Figure 4 Funnel plot – health outcomes.
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bias and country of origin may be confounded by other
differences between studies.
Implications of the study for policy and practice
As noted earlier, although many demand management
interventions are focussed on high users of health care,
many factors (such as the prevalence of high users, as
well as artefacts such as regression to the mean) reduce
the benefits of intervening in such groups [35]. Self-
management support thus has potential to make a large
impact on utilisation, because it is relevant to so many
patients with long-term conditions, but this assumes
that: (a) reductions in utilisation are achieved without
compromising other outcomes (b) reductions in utilisa-
tion can be consistently achieved (c) self-management
support can be disseminated widely.
Our review suggests that very few self-management in-
terventions compromise patient outcomes, at least among
those populations consenting to take part in trials. Studies
have suggested that self-management can lead to such
reactions in some patients, particularly those with mul-
timorbidity [36-38], but our data suggests that this is
not a consistent outcome.
The core issue thus relates to the impact of self-
management support on reducing utilisation. Across
conditions, the most robust effects (both in terms of
number of studies, and the size of the effects) related to
interventions in respiratory and cardiovascular patients,
where there was a significant evidence base suggesting
consistent (albeit small) reductions in hospital use and
costs in both self-management interventions and case
management, consistent with other reports in this area
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Figure 5 Funnel plot – hospital use.
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[39]. In terms of the wider implementation of self-
management support, many trials were based on small,
selected samples of volunteer patients, with isolated
examples of attempts at more widespread implementa-
tion [40,41].
Understanding the limited and inconsistent impact of
self-management requires examination of the assumptions
underlying self-management as a demand management
strategy. It is assumed that providing patients with self-
management support will either lead to indirect utilisation
benefits (where self-management leads to better health
and thus reduces utilisation) or more direct effects (for
example, where self-management enables more effective
response to exacerbations and crises, avoiding high cost
use such as hospital admission).
There are a number of potential problems with these
assumptions. Firstly, self-management interventions will
vary in their explicit targeting of utilisation behaviour.
As an example, self-management plans to control exacer-
bations in respiratory disorders often has a core function
to avoid unnecessary hospital use. In contrast, self-
management in diabetes may have as its aim patient em-
powerment and the improvement of diabetes control.
Variation in impacts between conditions may reflect
patterns of service delivery. For example, hospital use
related to depression may be relatively rare compared to
other conditions. There is also an assumption that util-
isation behaviour is patient-led, but some utilisation
(such as clinical attendance) may be led by professionals
[42]. Health service innovations designed to manage de-
mand may actually create supplier induced demand
[35]. Many self-management interventions have fairly
limited impacts; health outcomes will set important
limits on any indirect effects on utilisation, and even
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Figure 6 Funnel plot – total costs.
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effective self-management interventions may not lead to
enduring behaviour change. Few studies in the review
assessed outcomes over greater than 12 months, and
modelling of long term economic consequences of im-
proved health outcomes may be necessary.
Implications of the study for research
Analyses were hampered by poor reporting of outcome
data. We adopted a simple coding of types of self-
management interventions, but even assessments of
the amount of professional support provided were
often difficult. Few studies reported sufficient detail to
allow assessment of issues which might impact on rep-
licability of the interventions, especially around the
sensitivity of the interventions to particular cultures or
health care contexts. More consistent, comprehensive
and theory-led reporting of interventions and out-
comes would allow much more effective syntheses.
Our analyses suggested that impacts of self-management
support were patterned by type of long-term condition, but
the utility of disease specific analyses may be limited in the
context of increasing focus on multimorbidity. Patients
with multiple conditions may face the biggest barriers
to self-management [36], but may also have the greatest
capacity to benefit [31].
Clearly, further primary research could usefully develop
new models of self-management support that could
achieve consistent effects on utilisation, following con-
ventional models for the development of complex inter-
ventions [43] and drawing on relevant behavioural and
social science models relating to patient experience of
long-term conditions, as well as those relating to access
to care and utilisation.
There is also a need for a broader assessment of the
value of self-management in the context of wider service
redesign, as many models in this area highlight the in-
terrelationships between patients, professionals, and the
wider service context [13,44], which may be poorly
modelled by conventional trials.
Conclusions
Self-management support interventions rarely compro-
mised patient outcomes. There was evidence that self-
management support interventions can reduce hospital
use and total costs, although effects were generally small.
Evidence for significant reductions in utilisation were
strongest for interventions in respiratory and cardiovas-
cular disorders.
Reporting of data relevant to the core research question
was poor. Research priorities relate to better reporting of
the content of self-management support, exploration of
the impact of multimorbidity, and assessment of factors
influencing the wider implementation of self-management
support.
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